Atsushi Ochiai

Atsushi Ochiai

Auto-generated profile, based on publicly available information

Atsushi Ochiai

Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, Japan

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2008 in Cancer
Verified
Journal Article
Open access
PDF file
OKOsamu Kawai
Osamu Kawai
GIGenichiro Ishii
Genichiro Ishii
KKKaoru Kubota
Kaoru Kubota
YMYukinori Murata
Yukinori Murata
YNYoichi Naito
Yoichi Naito
AOAtsushi Ochiai
Atsushi Ochiai
BACKGROUND.: The purpose of this study was to investigate whether tumor‐infiltrating immune cells in biopsy specimens can be used to predict the clinical outcome of stage IV nonsmall cell lung cancer (NSCLC) patients.METHOD.: The authors performed an immunohistochemical study to identify and count the number of CD68+ macrophages, c‐kit+ mast cells, and CD8+ T cells in both cancer nests and cancer stroma in pretreatment biopsy specimens obtained from 199 patients with stage IV NSCLC treated by chemotherapy, and then analyzed for correlations between the number of immune cells and clinical outcome, including chemotherapy response and prognosis.RESULTS.: There was no correlation between the number of immune cells in either cancer nests or stroma and chemotherapy response. Patients with more tumor‐infiltrating macrophages in cancer nests than in cancer stroma (macrophages, nests > stroma) had significantly better survival than nests < stroma cases median survival time (MST 440 days vs 199 days; P < .0001). Patients with more tumor‐infiltrating CD8+ T cells in cancer nests than in cancer stroma (CD8+ T cells: nests > stroma) showed significantly better survival than in nests < stroma cases (MST 388 days vs 256 days; P = .0070). The proportion of tumor‐infiltrating macrophages or CD8+ T cells between cancer nests and stroma became independent prognostic factors in the multivariate analysis. Neither the number of mast cells in nests nor in stroma correlated with the clinical outcome.CONCLUSIONS.: Evaluation of the numbers of macrophages and CD8+ T cells in cancer nests and stroma are useful biomarkers for predicting the prognosis of stage IV NSCLC patients treated with chemotherapy, but could fail to predict chemotherapy response. Cancer 2008. © 2008 American Cancer Society.

14 July 2009 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
HFHiroshi Fujimoto
Hiroshi Fujimoto
TSTakafumi Sangai
Takafumi Sangai
GIGenichiro Ishii
Genichiro Ishii
AIAkashi Ikehara
Akashi Ikehara
TNTakeshi Nagashima
Takeshi Nagashima
AOAtsushi Ochiai
Atsushi Ochiai
There is growing evidence that tumor‐associated macrophages (TAMs) promote tumor growth and dissemination. Many individual reports have focused on the protumor function of molecules linked to the recruitment of macrophages, but little is known about which factor has the strongest impact on recruitment of macrophages in breast cancer. To elucidate this question, we performed RT‐PCR using species‐specific primers and evaluated tumoral and stromal mRNA expression of macrophage chemoattractants separately in human breast tumor xenografts. The correlation between the tumoral or stromal chemoattractant mRNA expression including monocyte chemoattractant protein‐1 (MCP‐1) (CCL2), MIP‐1α (CCL3), RANTES (CCL5), colony‐stimulating factor 1, tumor necrosis factor α, platelet‐derived growth factor (PDGF)‐BB and macrophage infiltration were compared. There was significant positive correlation between stromal MCP‐1 expression and macrophage number (r = 0.63), and negative correlation between tumoral RANTES expression and macrophage number (r = −0.75). However, no significant correlation was found for the other tumoral and stromal factors. The interaction between the tumor cells and macrophages was also investigated. Tumor cell–macrophage interactions augmented macrophage‐derived MCP‐1 mRNA expression and macrophage chemotactic activity in vitro. Treatment of immunodeficient mice bearing human breast cancer cells with a neutralizing antibody to MCP‐1 resulted in significant decrease of macrophage infiltration, angiogenetic activity and tumor growth. Furthermore, immunohistochemical analysis of human breast cancer tissue showed stromal MCP‐1 had a significant correlation with relapse free survival (p = 0.029), but tumoral MCP‐1 did not (p = 0.105). These findings indicate that stromal MCP‐1 produced as a result of tumor–stromal interactions may be important for the progression of human breast cancer and macrophages may play an important role in this tumor–stroma interaction. © 2009 UICC.

21 August 2008 in Cancer Science
Verified
Journal Article
Open access
PDF file
SFSatoshi Fujii
Satoshi Fujii
SMShuichi Mitsunaga
Shuichi Mitsunaga
MYManabu Yamazaki
Manabu Yamazaki
THTakahiro Hasebe
Takahiro Hasebe
GIGenichiro Ishii
Genichiro Ishii
AOAtsushi Ochiai
Atsushi Ochiai
Because autonomous proliferating cancer cells are often exposed to hypoxic conditions, there must be an alternative metabolic pathway, such as autophagy, that allows them to obtain energy when both oxygen and glucose are depleted. We previously reported finding that autophagy actually contributes to cancer cell survival in colorectal cancers both in vitro and in vivo. Pancreatic cancer remains a devastating and poorly understood malignancy, and hypoxia in pancreatic cancers is known to increase their malignant potential. In the present study archival pancreatic cancer tissue was retrieved from 71 cases treated by curative pancreaticoduodenectomy. Autophagy was evaluated by immunohistochemical staining with anti‐LC3 antibody, as LC3 is a key component of autophagy and has been used as a marker of autophagy. The results showed that strong LC3 expression in the peripheral area of pancreatic cancer tissue was correlated with a poor outcome (P = 0.0170) and short disease‐free period (P = 0.0118). Two of the most significant correlations among the clinicopathological factors tested were found between the peripheral intensity level of LC3 expression and tumor size (P = 0.0098) or tumor necrosis (P = 0.0127). Activated autophagy is associated with pancreatic cancer cells, and autophagy is thought to be a response to factors in the cancer microenvironment, such as hypoxia and poor nutrient supply. This is the first study to report the clinicopathological significance of autophagy in pancreatic cancer. (Cancer Sci 2008; 99: 1813–1819)

1 January 2004 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
SLSang-Chul Lim
Sang-Chul Lim
SZShichuan Zhang
Shichuan Zhang
GIGenichiro Ishii
Genichiro Ishii
YEYasushi Endoh
Yasushi Endoh
KKKeiji Kodama
Keiji Kodama
AOAtsushi Ochiai
Atsushi Ochiai
Purpose: Patients with oral tongue carcinoma treated by intraoral excision only should be followed up carefully for cervical lymph node metastasis and salvaged immediately if found, because some patients have a more aggressive clinical course. The purpose of this study was to find useful markers for predicting late cervical metastasis in patients with stage I and II invasive squamous cell carcinoma of the oral tongue. Experimental Design: We investigated clinicopathologic factors and immunohistochemical biomarkers predicting late cervical metastasis in surgical specimens from 56 patients with T1–2N0M0 invasive squamous cell carcinoma of the oral tongue who did not undergo elective neck dissection. Histopathologic factors including tumor thickness, mode of invasion, Broders grade, total score of three different malignancy grading systems, eight other clinicopathologic parameters, and immunohistochemical expression of p53, cyclin D1, Ki-67, epidermal growth factor receptor, microvessel density, cyclooxygenase-2, MUC1, laminin-5 γ2, E-cadherin, and β-catenin were examined. All of the clinicopathologic factors and immunohistochemical expression of biomarkers were compared in terms of survival. Results: In the univariate analysis, tumor thickness (P = 0.009), Broders grade (P = 0.017), nest shape (P = 0.005), mode of invasion (P < 0.001), Anneroth score (P = 0.029), Bryne score (P < 0.001), and E-cadherin expression (P = 0.003) were correlated with late cervical metastasis. Multivariate analysis on late cervical metastasis revealed that tumor thickness >4 mm, mode of invasion grade 3 or 4, and E-cadherin expression were independent factors. Late cervical metastasis was the only prognostic factor for overall survival (P = 0.002). Conclusions: Our results indicate that patients with stage I and II invasive squamous cell carcinoma of the oral tongue with tumor thickness >4 mm, mode of invasion grade 3 or 4, and low expression of E-cadherin should be considered a high-risk group for late cervical metastasis when a wait-and-see policy for the neck is adopted.

1 March 2004 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
KYKiyotaka Yoh
Kiyotaka Yoh
GIGenichiro Ishii
Genichiro Ishii
TYTomoyuki Yokose
Tomoyuki Yokose
YMYuji Minegishi
Yuji Minegishi
KTKohji Tsuta
Kohji Tsuta
AOAtsushi Ochiai
Atsushi Ochiai
Purpose: The purpose of this study was to investigate the relationship between the level of expression of ATP-binding cassette (ABC) transporter proteins, and response to chemotherapy and prognosis in advanced non-small cell lung cancer (NSCLC). Experimental Design: Expression of ABC transporter proteins, including P-glycoprotein, multidrug resistance protein (MRP) 1, MRP2, MRP3, and breast cancer resistance protein (BCRP), was examined immunohistochemically in 72 formalin-fixed tumor samples from untreated stage IIIB or IV NSCLC patients. All of the patients received platinum-based chemotherapy. Response to chemotherapy, progression-free survival (PFS), and overall survival were compared in relation to expression of each of the ABC transporter proteins and clinicopathological factors. Results: Expression of P-glycoprotein, MRP1, and MRP3 was not significantly associated with response to chemotherapy or survival. MRP2 expression was associated with overall survival (P = 0.002) but not with response to chemotherapy and PFS. By contrast, the response rate to chemotherapy of patients with BCRP-negative tumors was 44%, as opposed to 24% in patients with BCRP-positive tumors. Response rate was lower in BCRP-positive tumors, although this difference was not statistically significant (P = 0.08). BCRP-positive patients had also shorter PFS (P = 0.0003) and overall survival (P = 0.004) than BCRP-negative patients. Multivariate analysis confirmed BCRP status as an independent variable related to PFS (P = 0.001). Conclusions: Positive immunostaining for BCRP appears to be a predictor of survival in patients with advanced NSCLC. These findings indicate that BCRP may serve as a molecular target for reducing drug resistance to chemotherapy in advanced NSCLC patients.

14 September 2016 in Gastric Cancer
Verified
Journal Article
Closed access
PDF file
AKAkihito Kawazoe
Akihito Kawazoe
TKTakeshi Kuwata
Takeshi Kuwata
YKYasutoshi Kuboki
Yasutoshi Kuboki
KSKohei Shitara
Kohei Shitara
ANAkiko Kawano Nagatsuma
Akiko Kawano Nagatsuma
AOAtsushi Ochiai
Atsushi Ochiai